Delivery Order SPE2DB22D2206-SPE2DB25FDY46

Award Date 10/25/24
Potential Completion Date 10/28/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,058.81, is for the delivery of 4564541366 RISPERDAL 1 MG TABLET 60S through May 9, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $3,705.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of RISPERDAL 3 MG TABLET 60S, a pharmaceutical product, with a completion date of February 5, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of RISPERDAL 0.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $3,703.55 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 14, 2023. Amerisourcebergen is the prime contractor and does not have any listed subcontractors. The award is associated with a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,200.38 firm-fixed-price contract is for the delivery of RISPERDAL 0.5 MG TABLET 60S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract, valued at $1,964.44, is for the supply of 500 units of the 3 mg Risperidone tablet. The contract has a completion date of December 12, 2022 and uses a firm fixed-price pricing type. This contract award is a child of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,092.81 firm fixed price delivery order is for the supply of Risperdal 0.5 mg tablets. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide...
This federal contract award is a delivery order with a firm fixed price valued at $1,836.79, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of 4568618256 - RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,801.91 firm-fixed-price delivery order is for the supply of 60-count packages of 0.5 mg Risperidone tablets. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,295.20 Firm Fixed Price delivery order contract is for the supply of Risperidone 1 mg tablets to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award, with ID SPE2DB22D1106/SPE2DB24FFFT0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,129.49 fixed-price delivery order is for the supply of RISPERDAL 1 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holding several...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDY46
    Delivery Order

This federal contract award, valued at $1,489.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of RISPERDAL 1 MG TABLET UD 100S, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024 and a firm fixed-price pricing type. No set-aside designation was used for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a task order issued under the broader DLA IDC to meet the government's specific requirements for the RISPERDAL 1 MG TABLET UD 100S product.

Generated 1/24/25, 9:09 AM